These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Stolf BS; Santos MM; Simao DF; Diaz JP; Cristo EB; Hirata R; Curado MP; Neves EJ; Kowalski LP; Carvalho AF Cancer; 2006 May; 106(9):1891-900. PubMed ID: 16565969 [TBL] [Abstract][Full Text] [Related]
14. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland. Bhargav PR; Gayathri KB Indian J Pathol Microbiol; 2011; 54(2):414-5; author reply 415. PubMed ID: 21623114 [No Abstract] [Full Text] [Related]
15. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974 [TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia. Caria P; Vanni R Cancer Genet Cytogenet; 2010 Nov; 203(1):21-9. PubMed ID: 20951315 [TBL] [Abstract][Full Text] [Related]